 |
7 Products |  |
203 Diseases | | 7 Products |
|
6 Trials |  |
1256 News |  |
| «12...567891011121314151617 |
- ||| tirasemtiv (CK-2017357) / Astellas, Cytokinetics
Enrollment change: Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Aug 18, 2013
P2b, N=680, Completed, Sponsor: Cytokinetics
N=500 --> 680
- omecamtiv mecarbil (AMG 423) / Amgen, Servier
Enrollment change: Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency (clinicaltrials.gov) - Aug 8, 2013
P1, N=13, Completed, Sponsor: Amgen
N=500 --> 680 N=36 --> 13
- | omecamtiv mecarbil (AMG 423) / Amgen, Servier
Trial completion: Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency (clinicaltrials.gov) - Aug 8, 2013
P1, N=13, Completed, Sponsor: Amgen
N=36 --> 13 Recruiting --> Completed
- ispinesib (SB-715992) / Cytokinetics
Enrollment change, Metastases: SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (clinicaltrials.gov) - May 6, 2013
P2, N=33, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed N=21 --> 33
- ||||| omecamtiv mecarbil (AMG 423) / Amgen, Servier
New P2 trial: COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (clinicaltrials.gov) - Feb 6, 2013
P2, N=570, Recruiting, Sponsor: Amgen
- ispinesib (SB-715992) / Cytokinetics
Trial termination, Metastases: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Jan 10, 2013
P1, N=31, Terminated, Sponsor: National Cancer Institute (NCI)
N=21 --> 33 Completed --> Terminated; Administratively Complete.
- | omecamtiv mecarbil (AMG 423) / Amgen, Servier
New P1 trial: Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency (clinicaltrials.gov) - Nov 28, 2012
P1, N=13, Completed, Sponsor: Amgen
- tirasemtiv (CK-2017357) / Astellas, Cytokinetics
Trial termination: Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis (clinicaltrials.gov) - Oct 29, 2012
P2, N=32, Terminated, Sponsor: Cytokinetics
Completed --> Terminated; Administratively Complete. Recruiting --> Terminated; Closed after complete treatment of 32 patients after 21 months' recruitment.
- |||||| tirasemtiv (CK-2017357) / Astellas, Cytokinetics
New P2b trial: Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Oct 16, 2012
P2b, N=680, Completed, Sponsor: Cytokinetics
- ispinesib (SB-715992) / Cytokinetics
Trial completion, Metastases: SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes (clinicaltrials.gov) - Sep 10, 2012
P1, N=40, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Terminated; Closed after complete treatment of 32 patients after 21 months' recruitment. Active, not recruiting --> Completed
- ispinesib (SB-715992) / Cytokinetics
Trial completion, Metastases: Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer (clinicaltrials.gov) - Jul 19, 2012
P2, N=60, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | tirasemtiv (CK-2017357) / Astellas, Cytokinetics
Trial completion: Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Mar 11, 2012
P2, N=28, Completed, Sponsor: Cytokinetics
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | tirasemtiv (CK-2017357) / Astellas, Cytokinetics
Trial completion: A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Mar 11, 2012
P2, N=50, Completed, Sponsor: Cytokinetics
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | tirasemtiv (CK-2017357) / Astellas, Cytokinetics
New P2 trial: Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Dec 5, 2011
P2, N=28, Completed, Sponsor: Cytokinetics